Completed
US Treatment Algorithm - Resistance Profile: First Line Treatment Options Have The Lowest Resistance Rates
Class Central Classrooms beta
YouTube playlists curated by Class Central.
Classroom Contents
Treating Hepatitis B - Steven-Huy Han, MD - UCLA Digestive Diseases
Automatically move to the next video in the Classroom when playback concludes
- 1 Intro
- 2 Hepatitis B is a Devastating Global Healthcare Issue
- 3 Where Are the Long-term HBV Carriers?
- 4 Progression of Hepatitis B Infection
- 5 Diagnosis of HBV Infection: Using Serum Markers
- 6 FDA Approved Therapies for Chronic HBV
- 7 Treatment Criteria for Chronic Hepatitis B
- 8 Indications for antiviral therapy HBeAg Positive CHB
- 9 Indications for antiviral therapy HBeAg Negative CHB
- 10 Indications for antiviral therapy Compensated Cirrhosis
- 11 Endpoints of antiviral therapy HBeAg Positive CHB
- 12 HBeAg-Positive CHB Treatment Options: HBV DNA Loss at 1 Year
- 13 US Treatment Algorithm - Resistance Profile: First Line Treatment Options Have The Lowest Resistance Rates
